Pharmaceuticals
Amgen's $9.5-bn Onyx deal stumbles over cancer drug data
16 Aug 2013
While Onyx is not keen to obtain drug trial data before the study is over, Amgen feels the data would help it value the drug under trial
Mylan gets PMO nod to acquire Agila Specialities
16 Aug 2013
The prime ministers office today approved Mylan Inc’s proposal to acquire Indian company Agila Specialties for Rs5,500 crore, business channel CNBC-TV18 reported today
